Glucophage
Linagliptin Tradjenta is a dipeptidyl-peptidase-4 DPP-4 inhibitor labeled for the treatment of type 2 diabetes mellitus. Similar to sitagliptin Januvia and saxagliptin Onglyza, linagliptin delays the breakdown of endogenous incretin hormones such as glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide. |
COVID is an emerging, rapidly evolving situation. |
This treatment is designed for people with type 2 diabetes. |
Author Details. |
Nagpur, Maharashtra. |
It can change in a flash. |
Lowest Prices. Get the lowest prices on generic medications. |
You cannot be reimbursed in advance for any services. |
The first patient was enrolled on September 10, and the last patient concluded the study on May 4, Patients were excluded if they had a history of ketoacidosis or had unstable or rapidly progressive diabetic retinopathy, nephropathy, or neuropathy; impaired hepatic or renal function; or severe anemia. |
Ordering your treatment at OnlineClinic ensures that you can completely avoid the inconvenience of obtaining and attending a doctor's appointment. This highly effective diabetes treatment can be swiftly ordered at OnlineClinic after completing a simple online consultation. |









